Company Profile

E&B Technologies LLC (AKA: E And B Technologies)
Profile last edited on: 11/3/16      CAGE: 6TMV7      UEI:

Business Identifier: Developing treatment for uveitis
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

4868 Almondwood Way
San Diego, CA 92130
   (917) 628-8502
Location: Single
Congr. District: 52
County: San Diego

Public Profile

E&B Technologies LLC is a biotechnology company developing novel cell-therapy based treatments for eye diseases. As of 2014 the company was exploring a caveolin modulator therapeuty for Uveitis. E & B Technologies is developing an improved second generation cavtratin CVX for the treatment of uveitis. Uveitis is a swelling and irritation of the uvea, the middle layer of the eye and the primary source of blood supply to the retina. Uveitis is responsible for a large portion of blindness in the world.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2016 1 NIH $266,284
Project Title: Novel Caveolin Modulators as Therapeutics for Uveitis

Key People / Management

  David D Eveleth -- Managing Partner

Company News

There are no news available.